Bicara Therapeutics Inc. Common Stock (BCAX) vs Janux Therapeutics, Inc. (JANX)
A side-by-side comparison of Bicara Therapeutics Inc. Common Stock and Janux Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCAX
Bicara Therapeutics Inc. Common Stock
$16.58HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
JANX
Janux Therapeutics, Inc.
$16.93HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — BCAX vs JANX
growth of $100 · dividends reinvested · last 2yBCAX -26.1% (-14.1%/yr)JANX -64.5% (-40.4%/yr)BCAX compounded faster over this window
BCAX JANX
BCAX vs JANX: by the numbers
- •BCAX is the larger company ($1.09B vs $1.03B market cap).
- •Both run net losses; BCAX's is the smaller (0.00% vs -321.81% net margin).
Metrics side by side
Valuation
| Metric | BCAX | JANX |
|---|---|---|
| P/S ratio | N/A | 32.39 |
| P/B ratio | 2.32 | 1.11 |
Profitability
| Metric | BCAX | JANX |
|---|---|---|
| Gross margin | 0.00% | 79.71% |
| Operating margin | 0.00% | -1576.67% |
| Net margin | 0.00% | -321.81% |
| ROE | -39.54% | -11.06% |
| ROIC | -42.98% | -15.15% |
Growth (annualized)
| Metric | BCAX | JANX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 105.89% |
| Total return CAGR (5Y) | N/A | -6.45% |
Go deeper
Dig into the metrics
Bicara Therapeutics Inc. Common Stock ROEJanux Therapeutics ROEBicara Therapeutics Inc. Common Stock operating marginJanux Therapeutics operating marginBicara Therapeutics Inc. Common Stock revenue growthJanux Therapeutics revenue growthBicara Therapeutics Inc. Common Stock free cash flowJanux Therapeutics free cash flow
Bicara Therapeutics Inc. Common Stock & Janux Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.